Indisetron: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 1: Line 1:
'''Indisetron''' is a potent, highly selective [[5-HT3 receptor]] antagonist used in the prevention and treatment of [[chemotherapy]]-induced [[nausea]] and [[vomiting]]. It is a derivative of [[indazole]] and is structurally similar to other 5-HT3 receptor antagonists such as [[ondansetron]] and [[granisetron]].
{{Short description|A detailed overview of the antiemetic drug Indisetron}}


==Pharmacology==
==Indisetron==
Indisetron works by blocking the action of [[serotonin]], a natural substance that may cause nausea and vomiting. It does this by binding to and blocking the 5-HT3 receptors located in the [[central nervous system]] and [[gastrointestinal tract]], thereby preventing serotonin from activating these receptors.
[[File:Indisetron.svg|thumb|right|Chemical structure of Indisetron]]
'''Indisetron''' is a [[pharmaceutical drug]] used primarily as an [[antiemetic]] to prevent [[nausea]] and [[vomiting]] associated with [[chemotherapy]] and [[radiotherapy]]. It belongs to the class of [[5-HT3 receptor antagonists]], which work by blocking the action of [[serotonin]], a natural substance that may cause nausea and vomiting.


==Clinical Use==
==Mechanism of Action==
Indisetron is used primarily to control nausea and vomiting caused by chemotherapy. It is usually given before chemotherapy and may be continued for up to 24 hours afterwards. It can also be used to prevent nausea and vomiting after surgery.
Indisetron functions by selectively inhibiting the [[5-HT3 receptors]] located in the [[central nervous system]] and the [[gastrointestinal tract]]. By blocking these receptors, Indisetron prevents the binding of serotonin, thereby reducing the occurrence of nausea and vomiting. This mechanism is particularly effective in managing [[chemotherapy-induced nausea and vomiting]] (CINV).
 
==Pharmacokinetics==
Indisetron is administered orally or intravenously. After administration, it is rapidly absorbed and distributed throughout the body. The drug undergoes hepatic metabolism and is primarily excreted via the kidneys. The half-life of Indisetron allows for convenient dosing schedules, often aligning with chemotherapy sessions.
 
==Clinical Uses==
Indisetron is indicated for the prevention of:
* [[Chemotherapy-induced nausea and vomiting]] (CINV)
* [[Radiotherapy-induced nausea and vomiting]]
* Postoperative nausea and vomiting (PONV)


==Side Effects==
==Side Effects==
Common side effects of indisetron include [[headache]], [[dizziness]], and [[constipation]]. Less common side effects may include [[arrhythmia]], [[hypotension]], and [[seizure]]s. As with all medications, patients should be monitored for any adverse reactions.
Common side effects of Indisetron include:
* [[Headache]]
* [[Constipation]]
* [[Dizziness]]
* [[Fatigue]]
 
Less common but serious side effects may include:
* [[Allergic reactions]]
* [[QT interval prolongation]]


==Dosage==
==Contraindications==
The dosage of indisetron varies depending on the individual and the condition being treated. It is usually given by injection into a vein shortly before chemotherapy is started.
Indisetron should not be used in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with a history of [[cardiac arrhythmias]] due to the potential for QT interval prolongation.


==See Also==
==Related pages==
* [[5-HT3 receptor antagonist]]
* [[5-HT3 receptor antagonist]]
* [[Chemotherapy-induced nausea and vomiting]]
* [[Chemotherapy-induced nausea and vomiting]]
* [[Ondansetron]]
* [[Serotonin]]
* [[Granisetron]]
* [[Pharmacology]]
 
[[Category:5-HT3 antagonists]]
[[Category:Anti-emetics]]
[[Category:Indazoles]]


{{medicine-stub}}
[[Category:Antiemetics]]
[[Category:5-HT3 receptor antagonists]]
[[Category:Pharmacology]]

Latest revision as of 03:46, 13 February 2025

A detailed overview of the antiemetic drug Indisetron


Indisetron[edit]

Chemical structure of Indisetron

Indisetron is a pharmaceutical drug used primarily as an antiemetic to prevent nausea and vomiting associated with chemotherapy and radiotherapy. It belongs to the class of 5-HT3 receptor antagonists, which work by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

Mechanism of Action[edit]

Indisetron functions by selectively inhibiting the 5-HT3 receptors located in the central nervous system and the gastrointestinal tract. By blocking these receptors, Indisetron prevents the binding of serotonin, thereby reducing the occurrence of nausea and vomiting. This mechanism is particularly effective in managing chemotherapy-induced nausea and vomiting (CINV).

Pharmacokinetics[edit]

Indisetron is administered orally or intravenously. After administration, it is rapidly absorbed and distributed throughout the body. The drug undergoes hepatic metabolism and is primarily excreted via the kidneys. The half-life of Indisetron allows for convenient dosing schedules, often aligning with chemotherapy sessions.

Clinical Uses[edit]

Indisetron is indicated for the prevention of:

Side Effects[edit]

Common side effects of Indisetron include:

Less common but serious side effects may include:

Contraindications[edit]

Indisetron should not be used in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with a history of cardiac arrhythmias due to the potential for QT interval prolongation.

Related pages[edit]